A Prospective Observational Study to Assess the Efficacy of a SGLT2 Inhibitor (Dapagliflozin) in Kidney Allograft Recipients with Diabetes Mellitus

被引：0
|
作者：
Naskar, Avishek [1 ]
机构：
[1] Kolkata Kidney Inst, Kolkata, West Bengal, India
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 10期
关键词：
D O I：
10.1681/ASN.2024ej3cxwcq
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
TH-PO741
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The SGLT2 Inhibitor Dapagliflozin Significantly Improves the Peripheral Microvascular Endothelial Function in Patients with Uncontrolled Type 2 Diabetes Mellitus
    Sugiyama, Seigo
    Jinnouchi, Hideaki
    Kurinami, Noboru
    Hieshima, Kunio
    Yoshida, Akira
    Jinnouchi, Katsunori
    Nishimura, Hiroyuki
    Suzuki, Tomoko
    Miyamoto, Fumio
    Kajiwara, Keizo
    Jinnouchi, Tomio
    INTERNAL MEDICINE, 2018, 57 (15) : 2147 - 2156
  • [32] RISK OF KIDNEY DISEASE PROGRESSION AND EFFICACY OF SGLT2 INHIBITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Moura, Filipe
    Berg, David
    Bellavia, Andrea
    Mosenzon, Ofri
    Dwyer, Jamie
    Scirica, Benjamin M.
    Wiviott, Stephen
    Bhatt, Deepak L.
    Raz, Itamar
    Feinberg, Mark William
    Morrow, David A.
    Sabatine, Marc Steven
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1808 - 1808
  • [33] Case History: Forxiga™ (Dapagliflozin), a Potent Selective SGLT2 Inhibitor for Treatment of Diabetes
    Washburn, William N.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 49, 2014, 49 : 363 - 382
  • [34] The Effect of SGLT2 Inhibitor Dapagliflozin on BMI in Female Adolescents with Type 1 Diabetes
    Roman, R.
    Valdivia, N.
    Ruiz, S.
    HORMONE RESEARCH IN PAEDIATRICS, 2015, 84 : 13 - 13
  • [35] Remogliflozin etabonate: a novel SGLT2 inhibitor for treatment of diabetes mellitus
    Mikhail, Nasser
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (10) : 1381 - 1387
  • [36] Can SGLT2 Inhibitor be Used for Diabetes Mellitus or Vascular Diseases?
    Nomiyama, Takashi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2020, 27 (11) : 1139 - 1140
  • [37] SGLT2 Inhibition: A Novel Prospective Strategy in Treatment of Diabetes Mellitus
    Deshmukh, Aaishwarya B.
    Patel, Maharshi C.
    Mishra, Bharat
    RENAL FAILURE, 2013, 35 (04) : 566 - 572
  • [38] A Novel Therapeutic Agent for Type 2 Diabetes Mellitus: SGLT2 Inhibitor
    Jung, Chang Hee
    Jang, Jung Eun
    Park, Joong-Yeol
    DIABETES & METABOLISM JOURNAL, 2014, 38 (04) : 261 - 273
  • [39] A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation
    Christian Ott
    Agnes Jumar
    Kristina Striepe
    Stefanie Friedrich
    Marina V. Karg
    Peter Bramlage
    Roland E. Schmieder
    Cardiovascular Diabetology, 16
  • [40] A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation
    Ott, Christian
    Jumar, Agnes
    Striepe, Kristina
    Friedrich, Stefanie
    Karg, Marina V.
    Bramlage, Peter
    Schmieder, Roland E.
    CARDIOVASCULAR DIABETOLOGY, 2017, 16
12345